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 In 2011, Clinical Gastroenterology and Hepatology published our study “Prevalence and 
Variable Detection of Proximal Colon Serrated Polyps during Screening Colonoscopy”1. It is 
appropriate to first put this paper in context. At the time, there had been escalating concerns 
about colonoscopy’s imperfect protection against colorectal cancer (CRC), with observational 
studies suggesting that colonoscopy was significantly less effective in preventing deaths from 
right-sided colon cancer than left-sided CRC2,3. In parallel, the serrated neoplasia field was 
undergoing profound transformation, and emerging as an important factor in the CRC arena. 
Aiming to reorganize disparate and evolving histopathological criteria, the World Health 
Organization had just updated its classification of serrated colorectal neoplasms, grouping 
lesions under 3 major categories (hyperplastic, sessile serrated adenoma/polyp, and traditional 
serrated adenoma)4. In addition, progress was being made in elucidating the mechanisms 
involved in the serrated pathway to colorectal carcinogenesis5, including the observation that 
there was an overlap in the molecular features of post-colonoscopy CRCs and serrated 
neoplasms6,7. Serrated polyps are often located in the proximal colon and exhibit morphologic 
features which can render detection and complete resection challenging, even for experienced 
endoscopists. The effectiveness of colonoscopy as a screening modality depends on the quality 
of its performance, and variability in endoscopists’ adenoma detection rates (ADR) had been 
associated with the risk of post-colonoscopy CRC8. However, whether and to what extent this 
detection variability applied to proximal serrated polyps was uncertain.  
Using the Indiana University endoscopy database, we identified 6681 screening 
colonoscopies performed by 15 attending gastroenterologists, and determined detection rates of 
adenomas and serrated polyps. The proportion of colonoscopies with at least one adenoma was 
38% (range 17%-47%), and 13% for proximal serrated polyps (range 1%–18%). Adenoma and 
proximal serrated polyp detection rates per colonoscopy were strongly correlated (R = 0.76, P = 
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.0005). Endoscopist was associated with proximal serrated polyp detection (P < .0001), but 
patient age (P = .76) and gender (P = .95) were not. 
Ours was one of the first studies to demonstrate that detection of serrated lesions was 
even more variable than detection of conventional adenomas. One previous work reported 
variation in serrated polyp detection rates within the same group of endoscopists9. However, the 
18-fold variability in proximal serrated polyp detection we observed in the study published in 
CGH was novel and striking, and indicated significant shortcomings in some endoscopists’ 
ability to recognize these lesions. This was further supported by the observation that the 
endoscopist performing the procedure was a powerful predictor of proximal serrated polyp 
detection. Studies published subsequent to our work have confirmed that detection of proximal 
serrated polyps can be highly variable and endoscopist-dependent10,11.  
The serrated neoplasia field has evolved considerably and in exciting new directions 
since 2011. One development is the realization that the prevalence of the most relevant subtype 
of serrated polyps, the sessile serrated polyp (SSP), was higher than originally thought. We 
conducted a study12 including 1910 average-risk patients (≥ 50 years old) who had undergone 
screening colonoscopy by one endoscopist with high adenoma and serrated lesion detection 
rates, combined with a review of all slides of serrated lesions proximal to the sigmoid colon and 
rectal-sigmoid serrated lesions > 5 mm by one expert GI pathologist. The overall SSP 
prevalence in this study was 8.1%, of which about 7.4 % exhibited cytological dysplasia. A 
subsequent large Dutch study13 yielded similar results. Another important development is the 
recognition that serrated polyps are associated with increased risk of synchronous 14 and 
metachronous 15,16 neoplasia, with one study 15 showing that the risk of subsequent CRC 
development in patients with SSP was comparable to that of patients with conventional 
adenomas. Considerable progress has also been made in elucidating the molecular and clinical 
bases of the serrated pathway to CRC, including the most extreme manifestation of the serrated 
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milieu, the serrated polyposis syndrome17. The role of image-enhanced endoscopy to allow 
differentiation of SSPs from non-neoplastic lesions has been the focus of recent research, with 
the development of reliable algorithms such as the WASP 18 optical diagnosis classification, 
which combines the NBI International Colorectal Endoscopic (NICE) algorithms with surface 
features associated with SSP (clouded surface, indistinctive border, irregular shape, and dark 
spots inside crypts). The optimal polypectomy techniques for serrated polyps are also being 
refined. The CARE study 19 found that large serrated polyps were at highest risk for incomplete 
resection using conventional methods, likely due to their indistinct borders. However, 
subsequent reports20,21 showed that standardized dye-assisted endoscopic mucosal resection 
techniques could result in complete resection of SSPs which was at least as effective as for 
comparable-sized conventional adenomas. 
Serrated polyps have “come a long way” from the status of relative histopathological 
oddity, to recognition as being CRC precursors, and a suitable target for screening on par with 
conventional adenomas.  We believe our study was an important contribution along the way; it 
drew attention to the problem of variability in detection rates among endoscopists, and the need 
to increase efforts to educate providers to optimize recognition of serrated polyps. We are 
grateful to CGH and its Board of Editors for giving us the opportunity to share our findings with 
the medical community and increase awareness about the significance of serrated neoplasms.    
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